Drug intelligence / Profile preview

Donepezil and Folic Acid Combination

Development stage
Unknown
Lead developer
Eisai
Modality
Small Molecules
Administration
Oral
01

Overview

The combination of donepezil and folic acid is used as an adjunctive treatment for Alzheimer's disease. Donepezil is an acetylcholinesterase inhibitor that helps improve cognitive function in patients with Alzheimer's disease[4][5]. Folic acid supplementation has been shown to mitigate Alzheimer's disease by reducing inflammation and may provide additional benefits when combined with donepezil[2]. ## Mechanism and Efficacy Donepezil works by inhibiting acetylcholinesterase, which increases acetylcholine levels in the brain. This helps improve cognitive function in patients with mild, moderate, and severe Alzheimer's disease[4][5]. Folic acid supplementation helps reduce inflammation and homocysteine levels, which have been linked to Alzheimer's disease progression[2]. Studies have shown that the combination of donepezil with folic acid can lead to: - Improved Mini-Mental State Examination (MMSE) scores compared to donepezil alone[2] - Reduced levels of inflammatory markers like TNFα[2] - Altered amyloid beta ratios, potentially affecting disease progression[2] - Increased S-adenosylmethionine (SAM) levels and SAM/SAH ratio[2] In one study, patients receiving donepezil plus folic acid supplementation for 6 months showed significant improvements in cognitive function compared to those receiving donepezil alone[2]. ## Safety and Side Effects The combination therapy is generally well-tolerated. Common side effects associated with donepezil include: - Nausea - Insomnia - Diarrhea - Mild changes in heart rate[5] These side effects are typically mild and transient. No significant additional adverse effects have been reported when combining donepezil with folic acid supplementation[2][5]. ## Clinical Considerations When considering this combination therapy, healthcare providers should be aware of potential drug interactions. Donepezil may interact with: - Heart medications (amiodarone, atenolol, bisoprolol, digoxin, verapamil) - Epilepsy medications (phenytoin, carbamazepine) - NSAIDs (aspirin, ibuprofen) - Mental health medications (risperidone, olanzapine, fluoxetine) - Certain antibiotics (erythromycin, rifampicin) - St. John's wort (which can lower donepezil levels)[3] The combination of donepezil with folic acid appears to be a promising approach for enhancing the treatment of Alzheimer's disease, particularly by addressing both cholinergic dysfunction and inflammatory processes involved in the disease pathology.

02

Targets

Acetylcholinesterase

Beyond the preview

Go deeper on Donepezil and Folic Acid Combination.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Donepezil and Folic Acid Combination.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call